Tiger Eye Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MGM Resorts International
MGM
|
+$26.1M |
| 2 |
Expedia Group
EXPE
|
+$13.6M |
| 3 |
HCA Healthcare
HCA
|
+$11M |
| 4 |
Corpay
CPAY
|
+$10.7M |
| 5 |
JPMorgan Chase
JPM
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$59.2M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$38.5M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$22.6M |
| 4 |
Amazon
AMZN
|
+$17.2M |
| 5 |
GE Aerospace
GE
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 29.71% |
| 2 | Consumer Discretionary | 20.3% |
| 3 | Industrials | 16.46% |
| 4 | Financials | 13.47% |
| 5 | Technology | 7.8% |
Similar funds
Tiger Eye Capital's Q1 2021 Portfolio in Review
As of Q1 2021, Tiger Eye Capital held 74 positions worth $489M, down 14% from $568M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Tiger Eye Capital withdrew a net $103M in Q1 2021, closing 14 positions and reducing 22 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $22.6M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 30% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Tiger Eye Capital opened a new position in MGM Resorts International worth $28.4M.
- Tiger Eye Capital's largest Q1 2021 buy was MGM Resorts International: 747,009 shares worth $28.4M.
- Tiger Eye Capital added most to Corpay in Q1 2021, an estimated $10.7M increase.
- Tiger Eye Capital's biggest Q1 2021 reduction was People Inc, cutting an estimated $59.2M.
- Tiger Eye Capital fully exited Canadian Pacific Kansas City in Q1 2021, selling an estimated $22.6M.
- Tiger Eye Capital's ten largest holdings make up 59% of its $489M portfolio in Q1 2021.
- Tiger Eye Capital opened 22 new positions and closed 14 in Q1 2021.
- Tiger Eye Capital's portfolio value fell 14% quarter-over-quarter to $489M.
Based on Tiger Eye Capital's 13F filing for Q1 2021, filed 17 May 2021.